Norepinephrine deficiency is a state in which the body produces or releases too little norepinephrine, a chemical that serves as both a neurotransmitter in the brain and a hormone in the bloodstream. Because norepinephrine helps regulate blood pressure, alertness, attention, and mood, a shortfall can show up as anything from persistent dizziness upon standing to difficulty concentrating, fatigue, or depression. The causes range from rare genetic disorders that eliminate norepinephrine production entirely to the gradual nerve-cell loss seen in Parkinson’s disease, and even chronic stress can alter how the body handles this chemical over time.
What Norepinephrine Does and Why Running Low Matters
Norepinephrine works on two fronts. In the brain, it is produced mainly by a small cluster of neurons called the locus coeruleus, which sends projections across the cortex, hippocampus, and other regions. When those neurons fire, the norepinephrine they release sharpens sensory processing, supports flexible thinking and executive function in the frontal cortex, and helps consolidate memories in limbic structures.1Neuron. The Locus Coeruleus and Noradrenergic Modulation of Cognition Beyond cognition, locus coeruleus activity during mentally challenging or novel situations appears to help protect neurons from damage, which may partly explain why intellectually stimulating work and education are linked to preserved cognition in later life.2PubMed Central. The Locus Coeruleus: Essential for Maintaining Cognitive Function and the Aging Brain
Outside the brain, sympathetic nerve endings release norepinephrine directly onto blood vessels, the heart, and other organs. That release is what narrows blood vessels when you stand up, keeping blood pressure steady so your brain stays perfused. When sympathetic nerves fail to release enough norepinephrine at those vascular junctions, blood pressure can drop steeply on standing, a hallmark of what clinicians call neurogenic orthostatic hypotension.3PubMed. Diagnosing and treating neurogenic orthostatic hypotension in primary care Norepinephrine also acts locally inside lymphoid organs, where sympathetic nerve terminals release it onto immune cells, influencing immune responses.4PubMed Central. Impact of norepinephrine on immunity and oxidative metabolism in sepsis
Because the chemical sits at the intersection of so many systems, a deficiency rarely shows up as a single problem. People tend to experience a constellation of issues that span cardiovascular, cognitive, and emotional domains, and the specific pattern depends on whether the shortfall is in the brain, the peripheral nerves, or both.
Autonomic and Cardiovascular Symptoms
The most immediately noticeable sign of norepinephrine deficiency is trouble with blood pressure regulation. When you go from lying or sitting to standing, your body needs to quickly tighten blood vessels in the legs and abdomen. Without adequate norepinephrine at those sympathetic nerve endings, this constriction fails, and blood pools in the lower body. The result is a sharp drop in blood pressure that produces dizziness, lightheadedness, blurred vision, and sometimes fainting. Falls are a common and dangerous consequence.3PubMed. Diagnosing and treating neurogenic orthostatic hypotension in primary care
In the most severe form of norepinephrine deficiency, caused by a rare genetic enzyme defect (discussed below), patients have essentially no circulating norepinephrine or epinephrine at all. These individuals experience profound orthostatic hypotension from childhood or early adulthood, along with fatigue, exercise intolerance, and drooping eyelids (ptosis).5PubMed Central. Dopamine beta-hydroxylase deficiency But even partial deficiencies, such as those seen in Parkinson’s disease, can produce debilitating drops in blood pressure that limit a person’s ability to stand, walk, or carry out daily tasks.
Cognitive and Emotional Symptoms
Because the locus coeruleus supplies norepinephrine to attention and memory circuits throughout the brain, a central deficit tends to cloud thinking. People may notice problems sustaining focus, slower mental processing, difficulty shifting between tasks, and trouble consolidating new memories. These effects can be subtle early on, resembling ordinary forgetfulness or brain fog, and they often overlap with symptoms of depression or fatigue, which makes them easy to attribute to something else.
Research on post-infectious chronic fatigue illustrates the link between central norepinephrine activity and both mental and physical function. In one study, norepinephrine pathway activity in the brain correlated with scores on measures of mental health, physical functioning, vitality, and even grip endurance, while lower activity was associated with greater fatigue and cognitive complaints.6Brain Communications. Central noradrenergic deficiency in post-infectious chronic fatigue: neurobehavioral correlates This suggests that norepinephrine deficiency may be one biological mechanism behind the profound fatigue and mental sluggishness that some people experience after infections.
Norepinephrine has also been recognized as a key neurotransmitter in the pathophysiology of major depression. The noradrenergic system’s role is well established enough that several classes of antidepressants target norepinephrine reuptake, though in clinical practice serotonin-focused drugs have been more widely prescribed.7PubMed Central. The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects Apathy, low motivation, and difficulty experiencing pleasure are emotional symptoms sometimes attributed specifically to norepinephrine (as opposed to serotonin or dopamine) deficits, though in reality these neurotransmitter systems interact heavily and clean separations are hard to make.
The Rarest Cause, a Missing Enzyme
The most extreme version of norepinephrine deficiency comes from a genetic condition called dopamine beta-hydroxylase (DBH) deficiency. DBH is the enzyme that converts dopamine into norepinephrine. Without it, the entire downstream pathway stalls: dopamine accumulates in the bloodstream while norepinephrine and epinephrine are essentially absent.5PubMed Central. Dopamine beta-hydroxylase deficiency
This condition is inherited in an autosomal recessive pattern, meaning a child must receive a defective copy of the DBH gene from each parent. It is extremely rare. A long-term follow-up of reported cases found severely decreased or absent norepinephrine and epinephrine in nearly all patients examined, along with elevated dopamine levels.8PubMed Central. Clinical presentation and long-term follow-up of dopamine beta hydroxylase deficiency Patients typically present with severe orthostatic hypotension that can be life-disrupting from a young age, and the diagnosis is often delayed because the condition is so uncommon that clinicians may not think to look for it.
DBH deficiency is worth knowing about not because you are likely to have it, but because it provides a kind of natural experiment. By showing what happens when norepinephrine is completely absent, it confirms many of the functions attributed to the chemical and demonstrates just how essential it is for basic cardiovascular regulation.
Neurodegenerative Diseases and Locus Coeruleus Loss
Far more common than DBH deficiency is the gradual loss of norepinephrine-producing neurons that accompanies certain neurodegenerative diseases, particularly Parkinson’s disease and a related condition called multiple system atrophy (MSA). The locus coeruleus, that small brainstem nucleus responsible for most of the brain’s norepinephrine, degenerates early in Parkinson’s, sometimes even before the more famous dopamine-producing cells in the substantia nigra are significantly damaged.9PubMed Central. Neurogenic orthostatic hypotension in Parkinson’s disease: is there a role for locus coeruleus magnetic resonance imaging?
Imaging studies using specialized MRI techniques can now visualize the locus coeruleus in living patients. One study found that Parkinson’s patients with orthostatic hypotension had smaller locus coeruleus volumes than those without it, and patients with MSA had even smaller volumes still.10PubMed Central. Locus coeruleus degeneration is associated with orthostatic hypotension in Parkinson’s disease and multiple system atrophy Separate work using ultra-high-field MRI showed that the cell loss follows a specific pattern, concentrated in the tail end of the locus coeruleus, and that this caudal degeneration was associated with greater severity of non-motor symptoms including orthostatic hypotension and apathy.11PubMed. Blunted response of caudal locus coeruleus to arousing stimuli in Parkinson’s disease
This means that many of the “non-motor” symptoms of Parkinson’s, the ones patients often find most disabling day-to-day, may be driven less by the well-known dopamine deficit and more by the norepinephrine deficit that receives less attention. Dizziness on standing, apathy, difficulty concentrating, sleep disruption, and fatigue in Parkinson’s disease all have plausible connections to locus coeruleus deterioration.
Chronic Stress and Other Acquired Causes
You do not need a genetic disorder or a neurodegenerative disease to develop a norepinephrine imbalance. Chronic stress reshapes how the brain and body handle the chemical. Animal research has shown that repeated stress over weeks decreases the turnover of norepinephrine in the hypothalamus and hippocampus, meaning the system slows its production-and-recycling cycle.12Brain Research. Epinephrine, norepinephrine, dopamine and serotonin: Differential effects of acute and chronic stress on regional brain amines Over time, this could contribute to the flat mood, poor concentration, and emotional numbness that characterize burnout and stress-related depression.
Other situations that can reduce norepinephrine availability include:
- Nutritional deficits: The synthesis of norepinephrine depends on several building blocks and cofactors, including the amino acid tyrosine, vitamin C, copper, and vitamin B6. Severe deficiencies of any of these could theoretically constrain production, though overt norepinephrine deficiency from diet alone is rare in well-nourished populations.
- Medications: Certain blood-pressure drugs, some older antipsychotics, and drugs that deplete catecholamines (like reserpine) can lower norepinephrine levels. Abrupt withdrawal from stimulant medications or substances that boost norepinephrine may also produce a temporary crash.
- Aging: Locus coeruleus neurons decline with normal aging, though the rate and clinical impact vary widely between individuals. The connection between locus coeruleus integrity and cognitive preservation in old age is an active area of research.
How Norepinephrine Deficiency Is Evaluated
There is no single “norepinephrine level” test that straightforwardly tells you whether you are deficient. In clinical practice, the evaluation depends on which symptoms dominate.
For autonomic problems like orthostatic hypotension, doctors typically start with simple bedside tests, measuring blood pressure and heart rate while you lie down and then after you stand. A sustained drop in systolic blood pressure of at least 20 mmHg or diastolic of at least 10 mmHg within three minutes of standing is the standard threshold for orthostatic hypotension, and the heart-rate response helps distinguish neurogenic causes from other types.
Plasma catecholamine testing can add useful information. Measuring norepinephrine, epinephrine, dopamine, and their metabolites in the blood, especially when comparing levels while lying down versus standing, can help pinpoint where the problem lies. Plasma catechol measurement in patients with suspected autonomic disorders is rarely diagnostic on its own but is often informative when combined with the clinical picture.13PubMed Central. Roles of catechol neurochemistry in autonomic function testing The analytical methods have advanced considerably; modern high-performance liquid chromatography techniques with mass spectrometry provide sensitivity and specificity that older assays lacked.14PubMed. Measurement of catecholamines and their metabolites
In DBH deficiency specifically, the pattern is unmistakable: norepinephrine and epinephrine are extremely low or undetectable, while dopamine is strikingly elevated. In neurodegenerative disease, the picture is subtler, and specialized imaging of the locus coeruleus or cardiac sympathetic innervation may be used in research settings, though these are not yet routine clinical tools.
Distinguishing Norepinephrine Deficiency from Similar Conditions
Orthostatic dizziness and fatigue are common complaints with many possible causes, and not all of them involve norepinephrine deficiency. Two conditions that deserve mention because they can look similar but have different underlying mechanisms are postural orthostatic tachycardia syndrome (POTS) and neurocardiogenic syncope (also called vasovagal syncope).
In POTS, the heart rate rises excessively on standing, and patients experience many of the same symptoms as those with norepinephrine deficiency: dizziness, brain fog, fatigue, and exercise intolerance. But the norepinephrine picture in POTS is actually the opposite of what you would expect from deficiency. Research measuring norepinephrine spillover from the heart found that POTS patients had higher cardiac norepinephrine release than healthy controls, while patients with neurocardiogenic syncope had lower cardiac norepinephrine spillover.15Circulation. Cardiac sympathetic dysautonomia in chronic orthostatic intolerance syndromes The symptoms overlap, but the underlying catecholamine physiology diverges, which has direct implications for treatment.
Dehydration, anemia, adrenal insufficiency, and even simple deconditioning can also produce symptoms that mimic norepinephrine deficiency. A careful evaluation that considers the full clinical picture, not just standing blood pressure, is essential before attributing symptoms to a norepinephrine problem.
Treatment Approaches
Treatment depends on the severity and the underlying cause. For people with neurogenic orthostatic hypotension, whether from Parkinson’s disease, MSA, or other autonomic neuropathies, the most direct pharmacological option is droxidopa, a synthetic amino acid that the body converts into norepinephrine. Droxidopa was approved by the FDA specifically for the short-term treatment of neurogenic orthostatic hypotension; it raises blood pressure by increasing vascular tone at the neurovascular junction.16PubMed Central. Droxidopa in neurogenic orthostatic hypotension Other medications used include midodrine, which directly activates the receptors that norepinephrine would normally bind, and fludrocortisone, which works by expanding blood volume.
For cognitive and mood symptoms linked to norepinephrine deficiency, particularly in depression, several classes of medication act on the norepinephrine system. Serotonin-norepinephrine reuptake inhibitors (SNRIs) like venlafaxine and duloxetine block the recycling of both serotonin and norepinephrine, leaving more available in the synapse. Older tricyclic antidepressants have a similar dual effect, though with more side effects. The selective norepinephrine reuptake inhibitor atomoxetine, primarily used for attention-deficit/hyperactivity disorder, has shown mixed results when tried as an add-on treatment for depression.7PubMed Central. The noradrenergic action in antidepressant treatments: pharmacological and clinical aspects
Non-pharmacological measures matter too, especially for orthostatic hypotension. Increasing salt and fluid intake, wearing compression garments, sleeping with the head of the bed elevated, and rising slowly from sitting or lying positions can all help manage symptoms. These measures sound mundane, but for someone whose blood pressure drops every time they stand, they can mean the difference between independence and being housebound.
Exercise and Norepinephrine Levels
Physical activity is one of the most reliable ways to acutely boost norepinephrine release. Resistance training, in particular, appears to have lasting effects. A study of healthy men aged 50 to 65 found that a 16-week strength-training program increased resting plasma norepinephrine levels by about 36%, alongside increases in resting metabolic rate and fat-free mass.17PubMed Central. Strength training increases resting metabolic rate and norepinephrine levels in healthy 50- to 65-yr-old men The researchers attributed this partly to increased sympathetic nervous system activity.
For people with neurodegenerative or autonomic causes of norepinephrine deficiency, exercise is trickier. The very act of standing and exercising can provoke dangerous blood-pressure drops. Recumbent exercise, like cycling on a reclined bike or swimming, allows these individuals to get the cardiovascular and neurochemical benefits of physical activity without the gravitational challenge. If you have orthostatic hypotension, working with a physical therapist who understands autonomic dysfunction is worth the effort.
Sleep, the Locus Coeruleus, and What Happens at Night
The locus coeruleus has a distinctive firing pattern tied to the sleep-wake cycle. Its neurons are highly active during wakefulness, less active during lighter sleep stages, and nearly silent during REM sleep. This cycling is not a side effect; it is integral to how sleep architecture is organized. The locus coeruleus-norepinephrine system has been recognized for over five decades as a key substrate for regulating wakefulness and sleep transitions.18PubMed Central. Importance of the locus coeruleus-norepinephrine system in sleep-wake regulation: Implications for aging and Alzheimer’s disease
When the locus coeruleus degenerates, as it does in Parkinson’s disease and with aging, sleep fragmentation often follows. People wake frequently, spend less time in restorative deep sleep, and may experience excessive daytime sleepiness. These sleep problems can create a vicious cycle: poor sleep impairs the brain’s ability to clear metabolic waste (including proteins linked to Alzheimer’s disease), which may accelerate further neurodegeneration and additional locus coeruleus loss.
Norepinephrine and the Search for Neuroprotective Treatments
One of the more promising directions in Alzheimer’s disease research involves the norepinephrine system. The locus coeruleus is among the first brain regions to accumulate the abnormal tau protein that marks Alzheimer’s pathology, and its degeneration proceeds as the disease worsens. Animal studies have found that restoring norepinephrine levels can reverse some of the inflammatory and neurodegenerative changes associated with Alzheimer’s and may slow the progression of the disease.19PubMed Central. Targeting norepinephrine in mild cognitive impairment and Alzheimer’s disease
Whether these animal findings will translate to humans remains an open question. Clinical trials have tested norepinephrine-boosting drugs like atomoxetine in people with mild cognitive impairment, and early results suggest the approach is at least safe and biologically active, though definitive evidence of cognitive benefit in humans is not yet established. The idea is compelling: if locus coeruleus degeneration contributes to both the cognitive decline and the neuroinflammation seen in Alzheimer’s, then propping up norepinephrine levels early might slow the cascade. But “compelling” and “proven” are different things, and this line of research is still working through the gap between them.